CITCO as an Adjuvant Facilitates CHOP-Based Lymphoma Treatment in hCAR-Transgenic Mice

Non-Hodgkin’s lymphoma (NHL) is a malignant cancer originating in the lymphatic system with a 25–30% mortality rate. CHOP, consisting of cyclophosphamide (CPA), doxorubicin, vincristine, and prednisone, is a first-generation chemotherapy extensively used to treat NHL. However, poor survival rates am...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurian, Ritika, Hedrich, William, Mackowiak, Bryan, Li, Linhao, Wang, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700167/
https://www.ncbi.nlm.nih.gov/pubmed/33233444
http://dx.doi.org/10.3390/cells9112520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700167/
https://www.ncbi.nlm.nih.gov/pubmed/33233444
http://dx.doi.org/10.3390/cells9112520

Ejemplares similares